BOSCHI, STEFANO
BOSCHI, STEFANO
ARAG - AREA FINANZA E CONTABILITA'
Personale esterno ed autonomi
Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken'
2023 Boschi, Stefano; Todde, Sergio
Optimization of Precursor Preparation in PSMA-11 Radiolabeling to Obtain a Highly Reproducible Radiochemical Yield
2022 Iudicello, Antonella; Boschi, Stefano; Ghedini, Pietro; Lohr, Frank; Panareo, Stefano
PET radiopharmacy and automation
2022 Boschi, Stefano; Todde, Sergio
Production and Quality Control of [177Lu]Lu-PSMA-I&T: Development of an Investigational Medicinal Product Dossier for Clinical Trials
2022 Di Iorio, Valentina; Boschi, Stefano; Cuni, Cristina; Monti, Manuela; Severi, Stefano; Paganelli, Giovanni; Masini, Carla
[18F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality Issue
2021 Di Iorio, Valentina; Boschi, Stefano; Sarnelli, Anna; Cuni, Cristina; Bianchini, David; Monti, Manuela; Gorgoni, Giancarlo; Paganelli, Giovanni; Matteucci, Federica; Masini, Carla
An HPLC and UHPLC-HRMS approach to study PSMA-11 instability in aqueous solution
2021 Iudicello, Antonella; Genovese, Filippo; Di Iorio, Valentina; Cicoria, Gianfranco; Boschi, Stefano
From radiotracer to radiopharmaceutical: a philosophical approach
2021 Boschi, Stefano; Todde, Sergio
Ga-68-PSMA PET/CT for early restaging prostate cancer. Preliminary results of a prospective trial in patients with biochemical failure after radical therapy and PSA levels< 2 ng/mL
2016 francesco ceci; castellucci paolo; tiziano graziani; cristina fonti; filippo lodi; stefano boschi; stefano fanti
11C-Choline PET/CT in hormonal resistant patients after radical prostatectomy
2013 Francesco Ceci, Paolo Castellucci, Riccardo Schiavina, Chiara Fuccio, Stefano Boschi, Daniele Romagnoli, Elena Tabacchi, Marcelo Mamede, Cristina Nanni, Stefano Fanti
Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results
2013 Cristina Nanni; Riccardo Schiavina; Stefano Boschi; Valentina Ambrosini; Cinzia Pettinato; Eugenio Brunocilla; Giuseppe Martorana; Stefano Fanti
Generator breakthrough and radionuclidic purification in automated synthesis of 68Ga-DOTANOC
2013 Belosi F; Cicoria G; Lodi F; Malizia C; Fanti S; Boschi S; Marengo M.
Use of 65Zn as a tracer for the assessment of purification in the 68Ga-DOTANOC synthesis.
2013 Lucconi G.; Cicoria G.; Pancaldi D.; Lodi F.; Malizia C.; Fanti S.; Boschi S.; Marengo M.
11C-Choline PET/CT in patients with biochemical relapse after radical prostatectomy and PSA levels < 0.5 ng/mL
2012 Marcelo Mamede, Paolo Castellucci, Francesco Ceci, Riccardo Schiavina, Stefano Boschi, Valentina Ambrosini, Chiara Fuccio, Annarita Ianniello, Rossella Ferrara, Stefano Fanti
Synthesis of oncological [11C]radiopharmaceuticals for clinical PET.
2012 Lodi F.; Malizia C.; Castellucci P.; Cicoria G.; Fanti S.; Boschi S.
Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml?
2011 Castellucci P.; Fuccio C.; Rubello D.; Schiavina R.; Santi I.; Nanni C.; Allegri V.; Montini G.C.; Ambrosini V.; Boschi S.; Martorana G.; Marzola M.C.; Fanti S.
Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET.
2010 Pantaleo M.A.; Mishani E.; Nanni C.; Landuzzi L.; Boschi S.; Nicoletti G.; Dissoki S.; Paterini P.; Piccaluga P.P.; Lodi F.; Lollini P.L.; Fanti S.; Biasco G.
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET.
2010 Pantaleo M.A.; Nicoletti G.; Nanni C.; Gnocchi C.; Landuzzi L.; Quarta C.; Boschi S.; Nannini M.; Di Battista M.; Castellucci P.; Fanti S.; Lollini P.L.; Bellan E.; Castelli M.; Rubello D.; Biasco G.
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model.
2009 M.A. Pantaleo; L. Landuzzi; G. Nicoletti; C. Nanni; S. Boschi; G. Piazzi; D. Santini; M. Di Battista; P. Castellucci; F. Lodi; S. Fanti; P.-L. Lollini; G. Biasco
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma.
2009 Magini G; Farsad M; Frigerio M; Serra C; Colecchia A; Jovine E; Vivarelli M; Feletti V; Golfieri R; Patti C; Fanti S; Franchi R; Lodi F; Boschi S; Bernardi M; Trevisani F.
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer
2009 M.A. Pantaleo; M. Nannini; A. Maleddu; S. Fanti; C. Nanni; S. Boschi; F. Lodi; G. Nicoletti; L. Landuzzi; P. L. Lollini; G. Biasco
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Radiopharmaceutical need between the clinic and regulatory agencies: how philosophy could explain 'the road taken' | Boschi, Stefano; Todde, Sergio | 2023-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Optimization of Precursor Preparation in PSMA-11 Radiolabeling to Obtain a Highly Reproducible Radiochemical Yield | Iudicello, Antonella; Boschi, Stefano; Ghedini, Pietro; Lohr, Frank; Panareo, Stefano | 2022-01-01 | PHARMACEUTICALS | - | 1.01 Articolo in rivista | - |
| PET radiopharmacy and automation | Boschi, Stefano; Todde, Sergio | 2022-01-01 | NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Production and Quality Control of [177Lu]Lu-PSMA-I&T: Development of an Investigational Medicinal Product Dossier for Clinical Trials | Di Iorio, Valentina; Boschi, Stefano; Cuni, Cristina; Monti, Manuela; Severi, Stefano; Paganelli,... Giovanni; Masini, Carla | 2022-01-01 | MOLECULES | - | 1.01 Articolo in rivista | - |
| [18F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality Issue | Di Iorio, Valentina; Boschi, Stefano; Sarnelli, Anna; Cuni, Cristina; Bianchini, David; Monti, Ma...nuela; Gorgoni, Giancarlo; Paganelli, Giovanni; Matteucci, Federica; Masini, Carla | 2021-01-01 | PHARMACEUTICALS | - | 1.01 Articolo in rivista | - |
| An HPLC and UHPLC-HRMS approach to study PSMA-11 instability in aqueous solution | Iudicello, Antonella; Genovese, Filippo; Di Iorio, Valentina; Cicoria, Gianfranco; Boschi, Stefano | 2021-01-01 | EJNMMI RADIOPHARMACY AND CHEMISTRY | - | 1.01 Articolo in rivista | - |
| From radiotracer to radiopharmaceutical: a philosophical approach | Boschi, Stefano; Todde, Sergio | 2021-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Ga-68-PSMA PET/CT for early restaging prostate cancer. Preliminary results of a prospective trial in patients with biochemical failure after radical therapy and PSA levels< 2 ng/mL | francesco ceci; castellucci paolo; tiziano graziani; cristina fonti; filippo lodi; stefano boschi...; stefano fanti | 2016-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.06 Abstract in rivista | - |
| 11C-Choline PET/CT in hormonal resistant patients after radical prostatectomy | Francesco Ceci, Paolo Castellucci, Riccardo Schiavina, Chiara Fuccio, Stefano Boschi, Daniele Rom...agnoli, Elena Tabacchi, Marcelo Mamede, Cristina Nanni, Stefano Fanti | 2013-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 4.02 Riassunto (Abstract) | - |
| Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results | Cristina Nanni; Riccardo Schiavina; Stefano Boschi; Valentina Ambrosini; Cinzia Pettinato; Eugeni...o Brunocilla; Giuseppe Martorana; Stefano Fanti | 2013-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Generator breakthrough and radionuclidic purification in automated synthesis of 68Ga-DOTANOC | Belosi F; Cicoria G; Lodi F; Malizia C; Fanti S; Boschi S; Marengo M. | 2013-01-01 | CURRENT RADIOPHARMACEUTICALS | - | 1.01 Articolo in rivista | - |
| Use of 65Zn as a tracer for the assessment of purification in the 68Ga-DOTANOC synthesis. | Lucconi G.; Cicoria G.; Pancaldi D.; Lodi F.; Malizia C.; Fanti S.; Boschi S.; Marengo M. | 2013-01-01 | APPLIED RADIATION AND ISOTOPES | - | 1.01 Articolo in rivista | - |
| 11C-Choline PET/CT in patients with biochemical relapse after radical prostatectomy and PSA levels < 0.5 ng/mL | Marcelo Mamede, Paolo Castellucci, Francesco Ceci, Riccardo Schiavina, Stefano Boschi, Valentina ...Ambrosini, Chiara Fuccio, Annarita Ianniello, Rossella Ferrara, Stefano Fanti | 2012-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 4.02 Riassunto (Abstract) | - |
| Synthesis of oncological [11C]radiopharmaceuticals for clinical PET. | Lodi F.; Malizia C.; Castellucci P.; Cicoria G.; Fanti S.; Boschi S. | 2012-01-01 | NUCLEAR MEDICINE AND BIOLOGY | - | 1.01 Articolo in rivista | - |
| Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? | Castellucci P.; Fuccio C.; Rubello D.; Schiavina R.; Santi I.; Nanni C.; Allegri V.; Montini G.C....; Ambrosini V.; Boschi S.; Martorana G.; Marzola M.C.; Fanti S. | 2011-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET. | Pantaleo M.A.; Mishani E.; Nanni C.; Landuzzi L.; Boschi S.; Nicoletti G.; Dissoki S.; Paterini P....; Piccaluga P.P.; Lodi F.; Lollini P.L.; Fanti S.; Biasco G. | 2010-01-01 | MOLECULAR IMAGING AND BIOLOGY | - | 1.01 Articolo in rivista | - |
| Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. | Pantaleo M.A.; Nicoletti G.; Nanni C.; Gnocchi C.; Landuzzi L.; Quarta C.; Boschi S.; Nannini M.;... Di Battista M.; Castellucci P.; Fanti S.; Lollini P.L.; Bellan E.; Castelli M.; Rubello D.; Biasco G. | 2010-01-01 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model. | M.A. Pantaleo; L. Landuzzi; G. Nicoletti; C. Nanni; S. Boschi; G. Piazzi; D. Santini; M. Di Batti...sta; P. Castellucci; F. Lodi; S. Fanti; P.-L. Lollini; G. Biasco | 2009-01-01 | CLINICAL AND EXPERIMENTAL MEDICINE | - | 1.01 Articolo in rivista | - |
| C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. | Magini G; Farsad M; Frigerio M; Serra C; Colecchia A; Jovine E; Vivarelli M; Feletti V; Golfieri ...R; Patti C; Fanti S; Franchi R; Lodi F; Boschi S; Bernardi M; Trevisani F. | 2009-01-01 | CLINICAL NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | - |
| Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer | M.A. Pantaleo; M. Nannini; A. Maleddu; S. Fanti; C. Nanni; S. Boschi; F. Lodi; G. Nicoletti; L. L...anduzzi; P. L. Lollini; G. Biasco | 2009-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |